Trial · NCT05738148
Vasopressin vs. Epinephrine During Neonatal Cardiopulmonary Resuscitation
NCT05738148, Phase 1, Active not recruiting, University of Alberta
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Vasopressin vs. Epinephrine During Neonatal Cardiopulmonary Resuscitation. Trials, record NCT05738148. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT05738148
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Vasopressin vs. Epinephrine During Neonatal Cardiopulmonary Resuscitation
- NCT number
- NCT05738148
- Status
- Active not recruiting
- Phases
- Phase 1
- Enrollment
- 8 participants, estimated
- Lead sponsor
- University of Alberta
- Conditions
- Cardiac Arrest Neonatal
- Interventions
- Vasopressin, Epinephrine
- First posted
- 2023-02-21
- Last updated
- 2026-04-09
Source ClinicalTrials.gov
Registered outcomes14
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Time to ROSC (Return of spontaneous Circulation) | up to 60 Minutes of chest compression | Duration of Chest Compression until heart rate increases to greater 60 beats per minute, which is maintained for 60sec. |
| Secondary | Mortality | Within the first 28 days | Number of infants who die until discharge - comparison between group |
| Secondary | Number of Patients who have brain injury | Until infant is discharge from hospital (maximum of 30 weeks after birth) | Brain injury either by ultrasound or magnet resonance imaging - comparison between group |
| Secondary | Number of Epinephrine doses during resuscitation | During resuscitation (up to 60 minutes) | How many doses of epinephrine are given |
| Secondary | Number of Vasopressin doses during resuscitation | During resuscitation (up to 60 minutes) | How many doses of epinephrine are given |
| Secondary | Admission temperature | within 60 minutes after birth | body temperature at admission after birth |
| Secondary | Use of therapeutic cooling | First 72 hours after birth | Number of infants who receive therapeutic cooling during hospital admission |
| Secondary | Mode of mechanical ventilation | Until infant is discharge from hospital (maximum of 30 weeks after birth) | Number of infants who receive mechanical ventilation during hospital admission |
| Secondary | Cerebral regional oxygen saturation | First 72 hours after birth | Changes in Cerebral regional oxygen saturation measured using near-infrared spectrocopy |
| Secondary | Mask ventilation in the delivery room | up to 60 Minutes | Number of infants who receive mask ventilation during chest compression |
1 to 10 of 14Source ClinicalTrials.gov
See all 14 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 37663146 | DERIVED |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT05738148
GET https://conductscience.org/api/trials/v1/NCT05738148/registered